A popular Indian financial news platform liveMint recently reported that physicians from Bangladesh Medical College Hospital (BMCH), led by Dr. Tarek Alam, found that a combination of the anti-parasitic drug ivermectin in combination with antibiotic Doxycycline yielded “astounding results” against the novel coronavirus called SARS-CoV-2. The TrialSite Investigator Network is a database of over 100,000 clinical investigators leveraged by the TrialSite News team to contact Dr. Alam for a brief interview. He confirmed the positive results with their off-label use of ivermectin and Doxycycline to date and made some helpful clarifications.
TrialSite News systematically assesses news sources such as the liveMint, which is the online portal for Indian financial news media platform Mint, one of India’s premier business news publications—purportedly ranked second among business papers in terms of readership. The asset is owned by HT Media, a Delhi-based media group which is controlled by the KK Birla family and also publishes the Hindustan Times. It mostly targets a business audience. The group is owned by billionaire industrialist Kumar Birla. His father,...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).